Monitoring Minimal Residual Disease（MRD）in Pediatric B-acute Lymphoblastic Leukemia

RecruitingOBSERVATIONAL

Enrollment

255

Participants

Timeline

Start Date

January 30, 2021

Primary Completion Date

January 30, 2024

Study Completion Date

January 30, 2026

Conditions

B Acute Lymphoblastic Leukemia

Interventions

DIAGNOSTIC_TEST

Minimal residual disease (MRD) monitoring

Minimal residual disease (MRD) assay using IgH-V(D)J NGS and FCM

Trial Locations (1)

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors

lead

Sun Yat-sen University

OTHER